BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt Ø, Molberg Ø, Hoffmann-Vold AM. Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort. Rheumatology (Oxford) 2020;59:2920-9. [PMID: 32097470 DOI: 10.1093/rheumatology/keaa026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Didriksen H, Molberg Ø, Mehta A, Jordan S, Palchevskiy V, Fretheim H, Gude E, Ueland T, Brunborg C, Garen T, Midtvedt Ø, Andreassen AK, Lund-johansen F, Distler O, Belperio J, Hoffmann-vold A. Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension. Front Immunol 2022;13:991743. [DOI: 10.3389/fimmu.2022.991743] [Reference Citation Analysis]
2 Ferri C, De Angelis R, Giuggioli D, Bajocchi G, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Guiducci S, Girelli F, Riccieri V, Zanatta E, Bosello S, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Rossa AD, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Masini F, Gigante A, Bellando-randone S, Pellegrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Rozza D, Zanetti A, Carrara G, Landolfi G, Scirè CA, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'angelo S, Cozzi F, Doria A, Iannone F, Salvarani C, Matucci-cerinic M. Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature. Autoimmunity Reviews 2022. [DOI: 10.1016/j.autrev.2022.103159] [Reference Citation Analysis]
3 Tennøe AH, Murbræch K, Didriksen H, Ueland T, Palchevskiy V, Weigt SS, Fretheim H, Midtvedt Ø, Garen T, Brunborg C, Aukrust P, Molberg Ø, Belperio JA, Hoffmann-Vold AM. Serum markers of cardiac complications in a systemic sclerosis cohort. Sci Rep 2022;12:4661. [PMID: 35304587 DOI: 10.1038/s41598-022-08815-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Westerlind H, Bairkdar M, Gunnarsson K, Svensson J, Sysojev AÖ, Hesselstrand R, Holmqvist M. Incidence and prevalence of systemic sclerosis in Sweden, 2004-2015, a register-based study. Seminars in Arthritis and Rheumatism 2022. [DOI: 10.1016/j.semarthrit.2022.151978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hoffmann T, Oelzner P, Busch M, Franz M, Teichgräber U, Kroegel C, Schulze P, Wolf G, Pfeil A. Organ Manifestation and Systematic Organ Screening at the Onset of Inflammatory Rheumatic Diseases. Diagnostics 2022;12:67. [DOI: 10.3390/diagnostics12010067] [Reference Citation Analysis]
6 Hilberg O, Hoffmann-vold A, Smith V, Bouros D, Kilpeläinen M, Guiot J, Morais A, Clemente S, Daniil Z, Papakosta D, Fretheim H, Neves S, Alfaro TM, Antoniou KM, Valveny N, Asijee G, Soulard S, Wuyts W. Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries. ERJ Open Res 2022;8:00597-2021. [DOI: 10.1183/23120541.00597-2021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Hyldgaard C, Bendstrup E, Pedersen AB, Pedersen L, Ellingsen T. Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort. J Clin Med 2021;10:4830. [PMID: 34768349 DOI: 10.3390/jcm10214830] [Reference Citation Analysis]
8 Bairkdar M, Rossides M, Westerlind H, Hesselstrand R, Arkema EV, Holmqvist M. Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology (Oxford) 2021;60:3121-33. [PMID: 33630060 DOI: 10.1093/rheumatology/keab190] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hoffmann-Vold AM, Fretheim HH, Sarna VK, Barua I, Carstens MN, Distler O, Khanna D, Volkmann ER, Midtvedt Ø, Didriksen H, Dhainaut A, Halse AK, Bakland G, Pesonen M, Olsen I, Molberg Ø. Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial. BMJ Open 2021;11:e048541. [PMID: 34168032 DOI: 10.1136/bmjopen-2020-048541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Pauling JD, McGrogan A, Snowball J, McHugh NJ. Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink. Rheumatology (Oxford) 2021;60:2688-96. [PMID: 33212504 DOI: 10.1093/rheumatology/keaa680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 . Systemische Sklerose geht mit Multiorganerkrankungen einher. Aktuelle Rheumatologie 2021;46:222-222. [DOI: 10.1055/a-1295-5497] [Reference Citation Analysis]
12 Hoffmann-Vold AM, Molberg Ø. Detection, screening, and classification of interstitial lung disease in patients with systemic sclerosis. Curr Opin Rheumatol 2020;32:497-504. [PMID: 32890027 DOI: 10.1097/BOR.0000000000000741] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
13 Hoffmann-Vold AM, Bendstrup E, Dimitroulas T, Hesselstrand R, Morais A, Peltomaa R, Smith V, Welling J, Vonk MC, Wuyts WA. Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews. Rheumatology (Oxford) 2021:keab154. [PMID: 33587103 DOI: 10.1093/rheumatology/keab154] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Bruni C, Guignabert C, Manetti M, Cerinic MM, Humbert M. The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis. The Lancet Rheumatology 2021;3:e149-59. [DOI: 10.1016/s2665-9913(20)30356-8] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Lescoat A, Murphy SL, Roofeh D, Pauling JD, Hughes M, Sandler R, Zimmermann F, Wessel R, Townsend W, Chung L, Denton CP, Merkel PA, Steen V, Allanore Y, Del Galdo F, Godard D, Cella D, Farrington S, Buch MH, Khanna D. Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. J Scleroderma Relat Disord 2021;6:66-76. [PMID: 34316516 DOI: 10.1177/2397198320961967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
16 Hoffmann-Vold AM, Allanore Y, Bendstrup E, Bruni C, Distler O, Maher TM, Wijsenbeek M, Kreuter M. The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease. Respir Res 2020;21:197. [PMID: 32703199 DOI: 10.1186/s12931-020-01459-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]